Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Liver Neoplasms 2 Uveal Melanoma 1 Neuroendocrine Tumors 1 Hepatic Malignancies 1

Interventions

Ipilimumab 16 incomplete Freund's adjuvant 9 Nivolumab 9 sargramostim 6 Temozolomide 6 Dacarbazine 6 montanide ISA 51 5 MART-1 Antigen 5 Blood Specimen Collection 5 pembrolizumab 4 Ranibizumab 4 Melphalan 4 Interleukin-2 4 Carboplatin 4 CTLA-4 Antigen 4 Thalidomide 3 Surveys and Questionnaires 3 MAGEA3 protein, human 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 AZD 6244 3 sotrastaurin 2 relatlimab 2 gp100 Melanoma Antigen 2 fludarabine phosphate 2 fludarabine 2 entinostat 2 aflibercept 2 Taxes 2 Sunitinib 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uveal Melanoma × Sirtuins × Clear all

NCT02936388 2025-01-24

SirTac

Charite University, Berlin, Germany

Phase 2 Completed

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡